HOXA5 Inhibits Microglia Pyroptosis in Cerebral Stroke by Regulating FTO-Mediated TMEM59 m6A Demethylation

Lin Mou1,2, Lei Zheng3, Bo Wang1

  • 1Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, P.R. China.

Insights

HomeoboxA5 (HOXA5) deficiency exacerbates cerebral stroke by promoting microglia pyroptosis. HOXA5 upregulation inhibits neuroinflammation and brain injury by regulating FTO-mediated TMEM59 mRNA m6A modification.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Microglia pyroptosis is a key driver of neuroinflammation and secondary brain injury following cerebral stroke.
  • Understanding the molecular mechanisms that regulate microglia pyroptosis is crucial for developing effective stroke therapies.

Purpose of the Study:

  • To investigate the role of homeoboxA5 (HOXA5) in regulating microglia pyroptosis during cerebral stroke.
  • To elucidate the molecular pathway through which HOXA5 influences neuroinflammation and brain injury.

Main Methods:

  • Cerebral stroke models were induced using middle cerebral artery occlusion (MCAO) and oxygen-glucose deprivation/reoxygenation (OGD/R) in rats.
  • Cell viability, pyroptosis, infarct size, and neuronal damage were assessed using MTT assays, flow cytometry, TTC staining, and FJB staining, respectively.
  • Molecular interactions were analyzed via MeRIP, dual luciferase reporter, ChIP, and RIP assays to examine HOXA5, FTO, YTHDF2, and TMEM59 interactions and m6A modification.

Main Results:

  • HOXA5 expression was found to be downregulated in cerebral stroke models.
  • Overexpression of HOXA5 significantly reduced cerebral injury, infarct size, and neuronal damage in MCAO-induced stroke.
  • HOXA5 upregulation inhibited MCAO and OGD/R-induced microglia pyroptosis.
  • HOXA5 was shown to transcriptionally activate FTO expression, which in turn prevented TMEM59 mRNA degradation by reducing YTHDF2-mediated m6A modification.

Conclusions:

  • HOXA5 plays a protective role in cerebral stroke by inhibiting microglia pyroptosis.
  • The HOXA5/FTO/YTHDF2/TMEM59 axis represents a novel therapeutic target for mitigating neuroinflammation and secondary brain injury in stroke.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30